Hawkins, Inc. (HWKN) - 10-K Summary
Business Context and Reporting Period
Company: Hawkins, Inc.
Filing Type: Form 10-K (Annual Report)
Fiscal Period: Year ended March 29, 2026 (Fiscal 2026)
Business Overview: Hawkins is a leading water treatment and specialty ingredients company operating in three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. The company formulates, manufactures, distributes, and blends products for municipal, industrial, food, pharmaceutical, and agricultural customers.
Segment Realignment: Effective Q1 Fiscal 2026, the company realigned its reporting segments to better reflect its evolution from a bulk commodity distributor to a specialty ingredients company. Prior period data has been recast.
Key Financial Metrics
| Metric (in millions, except per share) | Fiscal 2026 | Fiscal 2025 |
|---|---|---|
| Total Sales | $1,083.7 | $974.4 |
| Gross Profit | $245.1 | $225.5 |
| Gross Margin | 22.6% | 23.1% |
| Operating Income | $121.3 | $119.2 |
| Net Income | $81.5 | $84.3 |
| Diluted EPS | $3.91 | $4.03 |
| Operating Cash Flow | $144.3 | $111.1 |
| Capital Expenditures | $58.2 | $41.1 |
| Long-Term Debt (Revolving) | $244.0 | $149.0 |
| Cash and Equivalents | $3.9 | $5.1 |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 11% ($109.3 million) driven by a 22% increase in the Water Treatment segment and a 7% increase in Industrial Solutions. The Food and Health Sciences segment declined slightly (1%) due to competitive pricing pressures.
- Acquisitions: The company completed six acquisitions in Fiscal 2026, most notably WaterSurplus, Inc. for $149.9 million (plus potential earnout). These acquisitions contributed approximately $48 million in annualized revenue and $83.3 million in sales to the Water Treatment segment.
- Profitability: While gross profit increased 9%, diluted EPS decreased 3% to $3.91. This decline was primarily due to increased interest expense ($13.5 million vs. $5.4 million) resulting from higher debt levels used to fund acquisitions, and increased SG&A expenses ($123.8 million) driven by acquisition-related costs and amortization.
- Liquidity: Operating cash flow improved significantly by 30% ($33.2 million) due to favorable changes in working capital (inventories and receivables). However, cash used in investing activities rose to $224.1 million due to acquisition spending and capital expenditures.
- Debt: Outstanding debt under the Revolving Loan Facility increased to $244 million from $149 million to finance the WaterSurplus acquisition and other growth initiatives.
Guidance, Outlook, and Risks
- Outlook: Management anticipates capital expenditures of approximately $55 million for Fiscal 2027. The company expects to remain in compliance with all credit agreement covenants for the next 12 months.
- Key Risks:
- Raw Material Volatility: Fluctuations in commodity prices (e.g., caustic soda) and supply chain disruptions can impact margins. The company does not hedge commodity prices.
- Seasonality: Water Treatment sales are seasonal (higher April-September), and agricultural sales depend on planting seasons and weather.
- Regulatory Environment: Subject to strict environmental, health, and safety regulations (EPA, FDA, DOT). Changes in regulations regarding chemicals (e.g., fluoride) could impact product viability.
- Transportation: Heavy reliance on third-party rail and trucking; disruptions or capacity constraints could delay shipments.
- Unusual Items: A $7.7 million environmental remediation charge for PCBs was recorded in Fiscal 2024 (not Fiscal 2026). In Fiscal 2026, the LIFO reserve increased, reducing gross profit by $1.5 million due to rising raw material costs.
Investor Verification Checklist
- Acquisition Integration: Verify the performance of the WaterSurplus acquisition (acquired April 2025) against the earnout targets and projected synergies.
- Debt Covenants: Monitor the Fixed Charge Coverage Ratio and Total Cash Flow Leverage Ratio to ensure continued compliance with the $400 million credit facility.
- Commodity Pricing: Assess the company's ability to pass through raw material cost increases to customers in the current inflationary environment.
- Segment Margins: Review the margin compression in the Food and Health Sciences segment due to competitive pricing pressures.
- Environmental Liabilities: Confirm the status of the $7.7 million PCB remediation liability and any potential additional environmental costs.